Codes / ICD10CM / T47.1X6S

T47.1X6S Underdosing of other antacids and anti-gastric-secretion drugs, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Underdosing of other antacids and anti-gastric-secretion drugs, sequela

Summary

This condition refers to the residual or chronic effects resulting from prior underdosing of medications classified as other antacids or anti-gastric-secretion drugs. It may manifest as unresolved symptoms or complications due to insufficient therapeutic exposure, even after the underdosing event has resolved.

Causes

Causes include prior missed doses, incorrect administration, or failure to adhere to prescribed regimens, leading to inadequate acid suppression. Underdosing can also result from confusion over instructions, cognitive impairment, or lack of access to medications, with lasting effects persisting after the initial dosing issue is addressed.

Risk Factors

  • Risk factors include polypharmacy, cognitive impairment, lack of health literacy, and conditions requiring long-term use of these agents. Pediatric or geriatric populations may be at higher risk due to dosing errors or difficulty managing regimens, potentially leading to sequela.

Symptoms

  • Symptoms may include persistent or worsening gastrointestinal issues such as heartburn, acid reflux, abdominal pain, or dyspepsia. Inadequate acid suppression can also lead to related complications like esophagitis or ulcer recurrence, which may persist as sequela.

Diagnosis

Diagnosis is based on patient history, review of prior medication adherence, and assessment of ongoing clinical response to therapy. Laboratory tests or imaging may be used to evaluate residual effects or complications, with a focus on correlating current symptoms to the prior underdosing event.

Treatment Options

Treatment focuses on addressing residual symptoms or complications, such as optimizing acid suppression or managing related conditions. Adjustments to medication regimens or additional therapies may be necessary to resolve ongoing issues resulting from the prior underdosing.

Prognosis and Follow-Up

Prognosis depends on the severity and duration of the prior underdosing and any resulting complications. Follow-up care may involve monitoring for symptom resolution, adjusting medications, or addressing underlying factors contributing to the sequela, with regular assessments to ensure therapeutic goals are met.

Complications

Complications can include persistent gastrointestinal symptoms, esophagitis, ulcer recurrence, or other acid-related conditions that may develop or worsen due to inadequate prior treatment. These complications may require additional interventions to manage effectively.

Lifestyle & Prevention

Lifestyle modifications, such as dietary adjustments or stress reduction, may help manage residual symptoms. Prevention involves ensuring proper medication adherence, clear dosing instructions, and regular follow-up to avoid future underdosing and its consequences.

When to Seek Professional Help

Seek professional help if symptoms persist or worsen, or if new complications arise. Prompt evaluation is important to address residual effects and prevent further progression of the sequela.

Tips for Medical Coders

Document the underlying condition or complication resulting from the prior underdosing, as well as any ongoing symptoms or treatments. Ensure the sequela is clearly linked to the original underdosing event, and include details on the duration and impact of the residual effects.

Book a walkthrough

T47.1X6S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.